Physician profile
Asad Khan
NPI 1225310394
$8,051.58
in general payments reported to CMS, 2019-2025
32 companies · $2,458 in 2025
The $2,458 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $932 · 2021: $935 · 2022: $596 · 2023: $720 · 2024: $1,139 · 2025: $2,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,061 · Travel and Lodging: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,061.23 |
| Travel and Lodging | $1,255.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,774.60 | 2021-2025 | Venaseal, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $995.41 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $764.88 | 2019-2022 | |
| Forte Bio-Pharma LLC | $763.37 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Abbott Laboratories | $537.08 | 2019-2025 | Proclaim, Octrode, Eterna |
| Boston Scientific Corporation | $502.50 | 2019-2025 | Wavewriter Alpha Prime 16, Varithena Administration Pack |
| Scilex Pharmaceuticals INC. | $444.07 | 2019-2024 | Ztlido |
| Medtronic USA, INC. | $350.47 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $311.64 | 2023-2025 | Relistor |
| Biodelivery Sciences International, INC. | $293.22 | 2019-2021 | |
| Horizon Therapeutics Plc | $255.83 | 2019-2022 | |
| Abbvie INC. | $175.68 | 2022-2024 | |
| Xtant Medical INC | $161.57 | 2023 | |
| Pfizer INC. | $133.48 | 2019-2024 | |
| Foundation Fusion Solutions, LLC | $80.27 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $69.05 | 2023-2025 | Horizant, Edarbyclor |
| Saluda Medical Americas, INC. | $66.33 | 2024-2025 | Evoke |
| Tonix Medicines, INC. | $63.87 | 2025 | Tonmya |
| Arbor Pharmaceuticals, INC. | $58.59 | 2019-2021 | |
| Avanos Medical | $31.07 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Allergan, INC. | $26.01 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $25.41 | 2021 | |
| Averitas Pharma INC. | $23.03 | 2024 | Qutenza |
| Siemens Medical Solutions USA, INC. | $21.31 | 2023 | Cios Select |
| Assertio Therapeutics, INC. | $19.00 | 2019 | |
| Zyla Life Sciences, INC. | $18.49 | 2020 | |
| Valinor Pharma, LLC | $17.69 | 2025 | Movantik |
| Vertex Pharmaceuticals Incorporated | $16.87 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.42 | 2022 | |
| Almatica Pharma LLC | $13.16 | 2021 | |
| Depuy Synthes Sales INC. | $12.68 | 2022 | |
| Shionogi INC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.